Titan Pharmaceuticals (TTNP)
NASDAQ:TTNP
US Market

Titan Pharmaceuticals (TTNP) Financial Statements

786 Followers

Titan Pharmaceuticals Financial Overview

Titan Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-6.326; its P/E ratio is -0.74; Titan Pharmaceuticals is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-$ 4.00K$ 83.00K$ 98.00K$ 120.00K
Gross Profit-$ 4.00K$ 83.00K--
EBIT$ 1.07M$ -338.00K$ -1.59M$ 1.89M$ -2.59M
EBITDA$ 1.07M$ -311.00K$ -1.55M$ 1.94M$ -2.10M
Net Income Common Stockholders$ -1.06M$ -338.00K$ -1.59M$ 1.92M$ -2.57M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.16M$ 8.10M$ 105.00K$ 1.14M$ 2.94M
Total Assets$ 6.65M$ 10.00M$ 812.00K$ 2.17M$ 4.06M
Total Debt$ 33.00K$ 97.00K$ 128.00K$ 158.00K$ 187.00K
Net Debt$ -6.13M$ -8.00M$ 23.00K$ -978.00K$ -2.75M
Total Liabilities$ 559.00K$ 1.87M$ 1.85M$ 2.48M$ 2.69M
Stockholders Equity$ 6.09M$ 8.13M$ -1.03M$ -312.00K$ 1.36M
Cash Flow-
Free Cash Flow$ -613.00K$ -1.61M$ -1.11M$ -1.90M$ -1.58M
Operating Cash Flow$ -613.00K$ -1.83M$ -1.11M$ -1.90M$ -1.58M
Investing Cash Flow-$ 228.00K---
Financing Cash Flow-$ 9.59M---
Currency in USD

Titan Pharmaceuticals Earnings and Revenue History

Titan Pharmaceuticals Debt to Assets

Titan Pharmaceuticals Cash Flow

Titan Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis